On May 13, 2018, Peter. M. Elias, M.D. received an Honorary Membership in the Society for Investigative Dermatology during their 2016 annual meeting in Atlanta GA. This award was given in recognition of his contributions to the present wealth of knowledge on the structure and myriad functions of the stratum corneum.
On June 15, 2013, Peter M. Elias, M.D., was awarded an International Honorary Membership in the Japanese Dermatological Association and delivered the Dohi Memorial Lecture to the Society at their annual meeting in Japan. The title of his presentation was: “Treating Atopic Dermatitis at the Source: Corrective Barrier Repair Based upon New Pathogenic Insights.”
Our work on antihistamines and the skin also featured in the May 2013 issue of Allure magazine. This work demonstrates that these commonly used drugs are applied directly to the skin they can improve the function of the skin barrier and also have potent anti-inflammatory effects. This work holds promise for the development of new treatments for common skin disorders like atopic dermatitis and psoriasis.
A new treatment for common skin diseases like psoriasis and eczema (or atopic dermatitis), or other skin conditions with a defective skin barrier, is the hope raised by recent work from the Elias laboratory and featured in Allure this month. These studies demonstrate that when antihistamines are applied topically to the skin, they improve the skin barrier. This suggests that creams or ointments containing anithistamines of the type that do not cause sedation as a side effect could provide a safe and effective way to treat inflammatory skin disorders caused in part by a defective skin barrier, like eczema and psoriasis.
On December 2, 2012, Dr. Peter Elias delivered the Joseph Von Plenck Lecture to the Austrian Society of Dermatology and Venereology during their annual meeting in Linz, Austria.